Supervivencia de los pacientes con cáncer de mama y próstata del régimen especial, y la oportunidad de inicios de tratamiento en relación con la actual pandemia SARS- COVID 19 en la UT Servisalud San José Bogotá D.C., en el periodo de 1 junio 2020 – 30 julio 2021

Robles, Lina Marcela Arana

doi:10.11144/javeriana.10554.59478

DOI: 10.11144/javeriana.10554.59478

|View full text |Cite

Supervivencia de los pacientes con cáncer de mama y próstata del régimen especial, y la oportunidad de inicios de tratamiento en relación con la actual pandemia SARS- COVID 19 en la UT Servisalud San José Bogotá D.C., en el periodo de 1 junio 2020 – 30 julio 2021

Lina Marcela Arana Robles¹

Abstract: Según los datos estadísticos del cáncer de mama y próstata y los escasos estudios de régimen especial de la UT Servislaud San José sobre la supervivencia para estos tipos de cáncer, se hace necesario describir la supervivencia global de esta población, poner a disposición alertas sobre los momentos de mayor riesgo y complicación de la enfermedad, contribuir con datos que apoyen y sustenten el diagnóstico precoz de los pacientes, apoyar las toma de decisiones en la efectividad de los tratamientos e inicios opo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Coronavirus disease 2019 and lung cancer: where are we?

Ocanto,

Mielgo-Rubio,

Luna Tirado

et al. 2023

Exploration of Targeted Anti-Tumor Therapy

View full text Add to dashboard Cite

Oncology patients are more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection due to hospital contact and an immunological system that can be compromised by antineoplastic therapy and supportive treatments. Certain similarities have been described in the physiopathology of coronavirus disease 2019 (COVID-19) and lung cancer (LC) that may explain the higher probability of these patients of developing a more serious disease with more frequent hospitalizations and even death, especially with the addition of smoking, cardiovascular and respiratory comorbidities, old age and corticosteroids use. Pre-existing lesions and cancer therapies change the normal architecture of the lungs, so diagnostic scales such as COVID-19 Reporting and Data System (CO-RADS) are of vital importance for a correct diagnosis and patient homogenization, with a high inter-observer correlation. Moreover, anticancer treatments have required an adaptation to reduce the number of visits to the hospital [hypofractionated radiotherapy (RT), larger intervals between chemotherapy cycles, delay in follow-up tests, among others]. In a way, this has also caused a delay in the diagnosis of new cancers. On the other hand, vaccination has had a positive impact on the mortality of these patients, who maintain a similar seroprevalence to the rest of the population, with a similar impact in mortality.

show abstract

Coronavirus disease 2019 and lung cancer: where are we?

Ocanto,

Mielgo-Rubio,

Luna Tirado

et al. 2023

Exploration of Targeted Anti-Tumor Therapy

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Supervivencia de los pacientes con cáncer de mama y próstata del régimen especial, y la oportunidad de inicios de tratamiento en relación con la actual pandemia SARS- COVID 19 en la UT Servisalud San José Bogotá D.C., en el periodo de 1 junio 2020 – 30 julio 2021

Cited by 1 publication

References 5 publications

Coronavirus disease 2019 and lung cancer: where are we?

Coronavirus disease 2019 and lung cancer: where are we?

Contact Info

Product

Resources

About